Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bentivegna

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Gynecologie, Obstetrique & Fertilite|March 25, 2011
[The accuracy of FDG-PET/CT in early-stage cervical and vaginal cancers]E Bentivegna, C Uzan, S Gouy, et al.
SN Comprehensive Clinical Medicine|August 25, 2020
COVID-19: is it just a lung disease? A case-based reviewValerio Spuntarelli, M Luciani, E Bentivegna, et al.
Gynecologie, Obstetrique, Fertilite & Senologie|February 26, 2021
[Epithelial ovarian cancers and minimally invasive cytoreductive surgery after neoadjuvant chemotherapy: A systematic review]G Achen, M Koual, E Bentivegna, et al.
La Radiologia Medica|June 1, 1997
[Server World-Wide Web on the Internet for the provision of clinical cases and digital radiologic images for training and continuing education in radiology]G Sparacia, M Tartamella, M Finazzo, et al.
International Angiology : a Journal of the International Union of Angiology|December 1, 1993
S.C.S. effectiveness in patients affected by peripheral chronic arterial disease: our 5 years experienceI Cassina, N M Pinelli, E Bentivegna, et al.
Brachytherapy|March 7, 2017
Brachytherapy as part of the conservative treatment for primary and recurrent vulvar carcinomaP Castelnau-Marchand, A Escande, R Mazeron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2016
Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC)S J L Mesnage, A Auguste, C Genestie, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Gynecologie, Obstetrique & Fertilite|March 25, 2011
[The accuracy of FDG-PET/CT in early-stage cervical and vaginal cancers]E Bentivegna, C Uzan, S Gouy, et al.
SN Comprehensive Clinical Medicine|August 25, 2020
COVID-19: is it just a lung disease? A case-based reviewValerio Spuntarelli, M Luciani, E Bentivegna, et al.
Gynecologie, Obstetrique, Fertilite & Senologie|February 26, 2021
[Epithelial ovarian cancers and minimally invasive cytoreductive surgery after neoadjuvant chemotherapy: A systematic review]G Achen, M Koual, E Bentivegna, et al.
La Radiologia Medica|June 1, 1997
[Server World-Wide Web on the Internet for the provision of clinical cases and digital radiologic images for training and continuing education in radiology]G Sparacia, M Tartamella, M Finazzo, et al.
International Angiology : a Journal of the International Union of Angiology|December 1, 1993
S.C.S. effectiveness in patients affected by peripheral chronic arterial disease: our 5 years experienceI Cassina, N M Pinelli, E Bentivegna, et al.
Brachytherapy|March 7, 2017
Brachytherapy as part of the conservative treatment for primary and recurrent vulvar carcinomaP Castelnau-Marchand, A Escande, R Mazeron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2016
Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC)S J L Mesnage, A Auguste, C Genestie, et al.
Pageof 2